ClinicalTrials.gg
RecruitingNCT07329400Updated Jan 13, 2026

Turkish Adaptation and Validation of the Burnt Hand Outcome Tool (BHOT)

An observational study in Hand Burn, Hand Injuries and Burn Injuries, sponsored by Necmettin Erbakan University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-13.

Sponsored by Necmettin Erbakan University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as recruiting.
  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Hand Injuries with a site in Turkey — 9 open to participants now, 9 under way, none of them phase 3. Hand Injuries · Turkey.

Started
2025
with 2 others
Observational
8 of 18
6 open now
Registered
11th of 18
by date

Among the 18 studies in Hand Injuries with a site in Turkey, this one is one of 3 that started in 2025, is one of 8 observational ones, and was the 11th registered.

Hand Injuries

122 studies on the registry are indexed under Hand Injuries; 35 are open to participants now.

Browse Hand Injuries studies →

Open to participants now

9 of the 18 studies in Hand Injuries with a site in Turkey are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 26 Hand Injuries studies recruiting now, 14 (54%) set no upper age limit and 10 (38%) stop at 75 or younger; 4 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Hand Injuries with a site in Turkey, or all of them as a file.
02

Study summary

The goal of this observational study is to evaluate the validity and reliability of the Turkish adaptation of the Burnt Hand Outcome Tool (BHOT) in adults with a history of hand burns. The participant population will include adults aged 18 years and older who have experienced unilateral or bilateral hand burns and can read and understand Turkish.The main questions this study aims to answer are:

Does the Turkish version of the BHOT demonstrate high internal consistency, test-retest reliability, and construct validity? How strongly are BHOT scores associated with objective hand function measures such as grip strength and sensory evaluation? Participants will not be assigned to comparison groups, as this is a methodological validation study.

Participants will: Complete a sociodemographic information form. Complete the Turkish version of the BHOT and the QuickDASH questionnaire. Undergo objective assessments including hand grip strength using a dynamometer and sensory evaluation using Semmes-Weinstein monofilaments. Participate in repeated assessments at baseline, 1 month, 3 months and 6 months for reliability analyses.

03

Conditions studied

  • Hand Burn
  • Hand Injuries
  • Burn Injuries

Keywords

  • Hand Burns
  • Burnt Hand Outcome Tool (BHOT)
  • Validation Study
  • Reproducibility of Results
  • Burn Injuries
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients aged 18 years and older with a history of second-degree or higher burn injury in one or both hands who are receiving outpatient or inpatient care at the burn unit. All participants are able to read and understand Turkish and provide informed consent.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • History of second-degree or higher burn injury in one or both hands
  • Ability to read and understand Turkish
  • Willingness to participate and provision of written

Exclusion criteria

Exclusion Criteria:

  • History of trauma, surgery, or rheumatologic disease affecting hand function prior to the burn injury
  • Age under 18 years
  • Cognitive impairment or psychiatric disorder preventing completion of the questionnaires
  • Refusal to participate or withdrawal from the study at any time
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Interventions

  • OtherBurnt Hand Outcome Tool (BHOT) - Turkish Version

    Assessment using the Turkish version of the Burnt Hand Outcome Tool (BHOT) for validity and reliability evaluation; no treatment is applied.

06

What researchers measure

Primary outcomes

  1. Reliability of the Turkish Version of the Burnt Hand Outcome Tool (BHOT)

    Total score of the Turkish version of the Burnt Hand Outcome Tool (BHOT-T), a patient-reported outcome measure assessing functional, aesthetic, sensory, and psychosocial outcomes in adults with hand burns. The BHOT-T consists of 20 items, each scored on a Likert scale. Total scores range from 0 to 80, with higher scores indicating worse outcomes / greater negative impact of hand burns on hand function and quality of life.

    Time frame: Baseline , 1 month, 3 months, and 6 months

  2. Construct Validity of Burnt Hand Outcome Tool-Turkish

    Construct validity will be assessed using confirmatory factor analysis (CFA) to evaluate the factor structure of the Turkish version of Burnt Hand Outcome Tool.

    Time frame: baseline, 1 month, 3 months, and 6 months

Secondary outcomes

  1. Convergent Validity With QuickDASH

    Total score of the Quick Disabilities of the Arm, Shoulder and Hand questionnaire (Quick DASH), a patient reported outcome measure assessing upper extremity disability. Scores are reported as units on a scale from 0 to 100, with higher scores indicating greater disability.

    Time frame: Baseline, 1 month, 3 months, and 6 months

  2. Hand Grip Strength

    Hand grip strength measured in kilograms (kg) using a hand dynamometer in adults with hand burns.

    Time frame: Baseline

  3. Sensory Function Assessment

    Sensory function of the hand assessed using the Semmes-Weinstein Monofilament Test, reported as monofilament level indicating cutaneous sensory threshold.

    Time frame: Baseline

  4. Discriminant Validity by Clinical Characteristics

    Discriminant validity will be evaluated by comparing total scores of the Turkish version of the Burnt Hand Outcome Tool (Burnt Hand Outcome Tool - Turkish version, BHOT-T) across predefined clinical subgroups, including burn severity, history of skin grafting, and working status.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Konya City Hospital (Konya Şehir Hastanesi)
    Konya, Meram, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Nov 2025 (actual). Primary completion is estimated for Apr 2026, 5 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 29, 2025
First posted
Jan 9, 2026
StartActual
Nov 17, 2025
Primary completionEst.
Apr 2026
CompletionEst.
Nov 2026
Last update
Jan 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07329400
Collaborators
Konya City Hospital
Responsible party
Pariya Pouriyamanesh (MSc student in Physiotherapy and Rehabilitation, Necmettin Erbakan University) — Principal investigator
First posted
Jan 9, 2026
Start date
Nov 17, 2025
Primary completion
Apr 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Jan 13, 2026

Study contacts

Pariya Puriyamanesh
Contact
fzt.pariya@gmail.com
+905538304970

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion